Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

SCTL - Societal CDMO, Inc.


Previous close
1.1
-0.890   -80.909%

Share volume: 0
Last Updated: Fri 05 Apr 2024 09:00:00 PM CEST
Pharmaceutical Preparation Manufacturing : 2.72%

PREVIOUS CLOSE
CHG
CHG%

$1.99
-0.89
-44.72%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
17%
Profitability 23%
Dept financing 18%
Liquidity 26%
Performance 10%
Company vs Stock growth
vs
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
239.51%
2 Year
-19.12%
Key data
Stock price
$1.10
P/E Ratio 
0.00
DAY RANGE
N/A - N/A
EPS 
$0.00
52 WEEK RANGE
$0.35 - $1.10
52 WEEK CHANGE
$213.84
MARKET CAP 
73.651 M
YIELD 
N/A
SHARES OUTSTANDING 
84.900 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.93
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
N/A
AVERAGE 30 VOLUME 
N/A
Company detail
CEO: J. David Enloe Jr.
Region: US
Website: www.societalcdmo.com
Employees: 275
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Preparation Manufacturing
Sector: Manufacturing

Societal CDMO, Inc., a contract development and manufacturing organization, engages in the research and development, manufacturing, and packaging for various therapeutic dosage forms primarily in the small molecules in the United States and internationally. It provides therapeutic development, end-to-end regulatory support, clinical and commercial manufacturing, aseptic fill/finish, lyophilization, packaging and logistics services to the global pharmaceutical market. The company was formerly known as Recro Pharma, Inc. and changed its name to Societal CDMO, Inc. in March 2022. Societal CDMO, Inc. was incorporated in 2007 and is based in Exton, Pennsylvania.

Recent news